Immuno-oncology drug development forges on despite COVID-19
Samik Upadhaya, Vanessa M. Hubbard-Lucey, Jia Xin Yu
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Drug developmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug2019-20 coronavirus outbreakMedicineDrug discoveryVirologyPharmacologyInternal medicineBioinformaticsBiologyInfectious disease (medical specialty)OutbreakDiseaseScience, Research, and MedicineEconomic and Financial Impacts of Cancer